Healthcare Equipment and Supplies
Company Overview of Vidacare Corporation
Vidacare Corporation develops, manufactures, and markets devices for medical, diagnostic, and therapeutic purposes worldwide. The company develops a technology platform that defines the field of intraosseous (IO) medicine with products indicated for vascular access, emergency and disaster medicine, hematology/oncology, and spinal surgery applications. It offers EZ-IO Intraosseous Vascular Access System, a battery-powered device to establish vascular access using the IO space and deliver essential medications and fluids for use in life support ambulances, emergency departments, and military customers; OnControl Bone Marrow System for clinicians to use in bone marrow biopsy and aspiration proc...
4350 Lockhill Selma Road
Shavano Park, TX 78249
Founded in 2001
Key Executives for Vidacare Corporation
Co-Founder and Executive Vice President of Vascular Access Sales
Vice President of U.S. Sales
Senior Director of Global Marketing - Teleflex
Compensation as of Fiscal Year 2014.
Vidacare Corporation Key Developments
Vidacare Corporation Launches the T.A.L.O.N.(TM) Intraosseous Vascular Access System
Aug 13 13
At the 2013 Military Health System Research Symposium (MHSRS) in Fort Lauderdale, Vidacare Corporation will be launching the T.A.L.O.N.(TM) (Tactically Advanced Lifesaving Intraosseous Needle) Intraosseous Vascular Access System for military use. The T.A.L.O.N. system is a groundbreaking single needle solution for vascular access that provides combat life savers and medics with rapid and accurate manual IO access to seven FDA cleared IO sites -- proximal tibia (below the knee), distal tibia (ankle), proximal humerus (shoulder) and the sternum. The T.A.L.O.N. system is the first IO system to meet all Committee on Tactical Casualty Care (CoTCCC) recommendations for IO devices. T.A.L.O.N. provides rapid vascular access through the intraosseous (inside the bone) space and helps deliver vital fluids and drugs through this space, the body's non-collapsible vein, to injured soldiers safely and quickly. T.A.L.O.N. is a non-powered vascular access option that complements Vidacare's powered EZ-IO(R) Intraosseous Vascular Access System that is widely utilized in combat medicine. This system is designed to provide battlefield responders a tactical advantage needed in the combat zone via its lightweight and minimal cube design, proven ability to gain vascular access quickly and safely, and its versatility because no additional intraosseous vascular access gear or tools are needed. As with any vascular access site, the IO insertion site should be monitored frequently and the system should be used only when anatomical landmarks can be clearly identified and in accordance with the T.A.L.O.N. system's instructions for use. The T.A.L.O.N. system will be commercially available in the United States starting in early in the fourth quarter of 2013.
Vidacare Mulls Acquisitions
May 24 13
Vidacare Corporation expects $70 million of revenues in 2013 and plans to leverage that momentum, pursuing expansion and acquisition opportunities in the U.S. and abroad. Vidacare is looking to expand its presence in the biotech arena. "This opens up a chance for us to look at other products, and to look at acquisition opportunities," Mark Mellin, President and Chief Executive Officer of Vidacare said. Vidacare is planning to secure a business development manager who will help identify acquisition opportunities.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries